BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Events - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://events.ucsc.edu
X-WR-CALDESC:Events for Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260108T114000
DTEND;TZID=America/Los_Angeles:20260108T131500
DTSTAMP:20260427T101556
CREATED:20251216T231619Z
LAST-MODIFIED:20251216T231619Z
UID:10005856-1767872400-1767878100@events.ucsc.edu
SUMMARY:BME 280B Seminar: Nature’s Miniature Masterpieces - Nanobodies as Small but Mighty Antibodies for the next Pandemic
DESCRIPTION:Presenter: Katja Hanack\, Founder and CEO\, New/Era/Mabs \nDescription: Nanobodies combine remarkable simplicity with surprising power. Their small size allows them to reach targets that remain inaccessible to conventional antibodies\, while maintaining high specificity and stability. Their compact architecture allows them to access targets that conventional antibodies cannot reach\, yet they preserve the specificity and power that make antibody therapeutics so transformative. In this talk I will introduce the science behind selma\, a cell based discovery platform developed over more than a decade to rapidly identify high quality antibodies and nanobodies. I will explore why these tiny binders matter\, how they differ from classical antibodies\, and what their unique biology enables for diagnostics and therapeutics. \nThe presentation will conclude with my current project on immune infrastructure and how pre validated nanobody archives can shift the pandemic response from a reactive model to proactive preparedness for future outbreaks. \nBio: Katja Hanack\, PhD\, MBA\, is the Founder and CEO of new/era/mabs and a leading expert in antibody discovery for diagnostic and therapeutic applications\, with a particular focus on nanobody technologies. With more than 20 years of experience\, she has developed pioneering platforms that enable the efficient generation and selection of next-generation monoclonal antibodies and nanobodies. She holds a Biology degree from Humboldt University of Berlin and a PhD in Biotechnology from the University of Potsdam. As a former Professor of Biochemistry and Biology at the University of Potsdam\, she built and led a research group of 25 scientists\, secured over €16 million in external funding\, and authored more than 40 peer-reviewed publications. Since 2017\, Dr. Hanack has contributed to translational innovation as an industrial advisor for SPARK Stanford and SPARK Berlin\, supporting academic teams in bringing biomedical discoveries to patients. \nHosted by: Professor Rebecca Dubois\, BME Department
URL:https://events.ucsc.edu/event/bme-280b-seminar-natures-miniature-masterpieces-nanobodies-as-small-but-mighty-antibodies-for-the-next-pandemic/
LOCATION:Physical Sciences Building\, Physical Sciences Building\, Santa Cruz\, CA\, 95064
CATEGORIES:Lectures & Presentations,Seminars
ATTACH;FMTTYPE=image/jpeg:https://events.ucsc.edu/wp-content/uploads/2025/12/Foto_KH.jpg
GEO:36.9996638;-122.0618552
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Physical Sciences Building Physical Sciences Building Santa Cruz CA 95064;X-APPLE-RADIUS=500;X-TITLE=Physical Sciences Building:geo:-122.0618552,36.9996638
END:VEVENT
END:VCALENDAR